Apyx Medical Corporation (APYX)
After hours:
| Previous Close | 1.2000 |
| Open | 1.1700 |
| Bid | 0.8496 x 200 |
| Ask | 1.5300 x 200 |
| Day's Range | 1.1608 - 1.2000 |
| 52 Week Range | 0.9670 - 3.2600 |
| Volume | |
| Avg. Volume | 36,471 |
| Market Cap | 40.88M |
| Beta (5Y Monthly) | 1.20 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
Renuvion Named #1 Trusted Body Contouring Technology by Doctors*
Apyx® Medical Corporation (NASDAQ: APYX) ("Apyx Medical;" the "Company"), a leader in advanced energy technology and the manufacturer of Renuvion®, today announced that doctors named Renuvion as the #1 trusted body contouring technology in an independent survey by Wakefield Research.** This recognition underscores the effectiveness of Renuvion's novel technology that targets loose skin at the source, offering unparalleled results for body contouring procedures.
- Business Wire
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures
CLEARWATER, Fla., August 08, 2024--Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical"; the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced the publication of a peer-reviewed article in the journal, Plastic and Reconstructive Surgery—Global Open, featuring the results of study which compared the use of Renuvion’s Helium Plasma Technology to InMode’s Bipolar RF System ("Bipolar RF") following lip
- Business Wire
Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook
CLEARWATER, Fla., August 08, 2024--Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today reported financial results for its second quarter ended June 30, 2024; and updated its financial expectations for the full year ending December 31, 2024.
